Codexis Inc
CDXS2.791USD
+0.101+3.75%
交易中 （美東）報價延遲15分鐘
231.20M總市值
虧損本益比TTM
關於 Codexis Inc 公司
Codexis, Inc. 是一家酶工程公司。該公司正在利用其 CodeEvolver 技術平臺來發現、開發、增強和商業化新型高性能酶和其他類別的蛋白質。該公司利用其 CodeEvolver 技術平臺開發優化的酶，一些製藥公司使用這些酶來降低成本並提高小分子療法制造工藝的效率和生產力。該公司正在開發其酶催化寡核苷酸合成 (ECO Synthesis) 製造平臺，以便通過酶促途徑大規模生產 RNA 干擾 (RNAi) 療法。該公司還使用 CodeEvolver 平臺技術開發用於合成核酸（例如 DNA/RNA）的酶，包括其 ECO Synthesis 製造平臺中使用的酶，其酶有望提供其在製藥製造中提供的許多相同優勢。
公司簡介
公司代碼CDXS
公司名稱Codexis Inc
上市日期Apr 22, 2010
CEODr. Stephen G. Dilly, Ph.D.
員工數量188
證券類型Ordinary Share
年結日Apr 22
公司地址200 Penobscot Dr
城市REDWOOD CITY
上市交易所NASDAQ Global Select Consolidated
國家United States of America
郵編94063
電話16504218100
網址https://www.codexis.com/
公司代碼CDXS
上市日期Apr 22, 2010
CEODr. Stephen G. Dilly, Ph.D.
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. David V. Smith
Mr. David V. Smith
Lead Independent Director
Lead Independent Director
194.28K
+26.74%
Mr. Kevin Norrett
Mr. Kevin Norrett
Chief Operating Officer
Chief Operating Officer
160.27K
+10.73%
Mr. Dennis P. Wolf
Mr. Dennis P. Wolf
Independent Director
Independent Director
147.90K
+38.33%
Dr. Rahul Singhvi
Dr. Rahul Singhvi
Independent Director
Independent Director
132.05K
+45.00%
Dr. Esther Martinborough, Ph.D.
Dr. Esther Martinborough, Ph.D.
Independent Director
Independent Director
129.04K
+46.54%
Ms. Cynthia Collins
Ms. Cynthia Collins
Independent Director
Independent Director
112.16K
+57.58%
Dr. Alison Moore, Ph.D.
Dr. Alison Moore, Ph.D.
Executive Vice President, Chief Technical Officer
Executive Vice President, Chief Technical Officer
98.70K
-43.79%
Dr. Raymond De Vre, Ph.D.
Dr. Raymond De Vre, Ph.D.
Independent Director
Independent Director
88.83K
+85.66%
Mr. Christos Richards
Mr. Christos Richards
Independent Director
Independent Director
85.13K
+92.83%
Ms. Georgia L. Erbez
Ms. Georgia L. Erbez
Chief Financial Officer
Chief Financial Officer
76.88K
+53.75%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. David V. Smith
Mr. David V. Smith
Lead Independent Director
Lead Independent Director
194.28K
+26.74%
Mr. Kevin Norrett
Mr. Kevin Norrett
Chief Operating Officer
Chief Operating Officer
160.27K
+10.73%
Mr. Dennis P. Wolf
Mr. Dennis P. Wolf
Independent Director
Independent Director
147.90K
+38.33%
Dr. Rahul Singhvi
Dr. Rahul Singhvi
Independent Director
Independent Director
132.05K
+45.00%
Dr. Esther Martinborough, Ph.D.
Dr. Esther Martinborough, Ph.D.
Independent Director
Independent Director
129.04K
+46.54%
Ms. Cynthia Collins
Ms. Cynthia Collins
Independent Director
Independent Director
112.16K
+57.58%
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
暫無數據
地區USD
名稱
營收
佔比
EMEA
3.92M
51.96%
America
2.09M
27.68%
APAC
1.54M
20.36%
業務
地區
暫無數據
股東統計
更新時間: 7月12日 週六
更新時間: 7月12日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Opaleye Management Inc.
14.79%
Casdin Capital, LLC
9.78%
BlackRock Institutional Trust Company, N.A.
7.52%
The Vanguard Group, Inc.
5.70%
Fidelity Management & Research Company LLC
5.20%
Other
57.00%
持股股東
持股股東
佔比
Opaleye Management Inc.
14.79%
Casdin Capital, LLC
9.78%
BlackRock Institutional Trust Company, N.A.
7.52%
The Vanguard Group, Inc.
5.70%
Fidelity Management & Research Company LLC
5.20%
Other
57.00%
股東類型
持股股東
佔比
Investment Advisor
35.15%
Hedge Fund
29.92%
Investment Advisor/Hedge Fund
21.10%
Individual Investor
2.84%
Research Firm
1.29%
Pension Fund
0.23%
Bank and Trust
0.20%
Insurance Company
0.01%
Other
9.25%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
284
75.54M
91.18%
-4.83M
2025Q1
321
69.35M
83.91%
-9.24M
2024Q4
334
67.97M
82.44%
-9.17M
2024Q3
341
66.67M
93.65%
-3.04M
2024Q2
355
56.24M
79.41%
-16.85M
2024Q1
368
57.66M
81.73%
-20.93M
2023Q4
384
58.98M
84.48%
-18.95M
2023Q3
392
59.46M
85.28%
-19.41M
2023Q2
387
64.66M
96.86%
-12.85M
2023Q1
391
64.45M
97.75%
-12.56M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Opaleye Management Inc.
12.24M
14.78%
+250.00K
+2.08%
Jun 16, 2025
Casdin Capital, LLC
8.10M
9.78%
--
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
6.23M
7.52%
+27.40K
+0.44%
Mar 31, 2025
The Vanguard Group, Inc.
4.72M
5.7%
+261.14K
+5.85%
Mar 31, 2025
Fidelity Management & Research Company LLC
4.31M
5.2%
+50.27K
+1.18%
Mar 31, 2025
abrdn Inc.
606.29K
0.73%
+97.67K
+19.20%
Mar 31, 2025
Telemark Asset Management, LLC
3.00M
3.62%
--
--
Mar 31, 2025
Nantahala Capital Management, LLC
2.83M
3.42%
-11.04K
-0.39%
Mar 31, 2025
Columbia Threadneedle Investments (US)
2.53M
3.06%
+135.06K
+5.63%
Mar 31, 2025
Geode Capital Management, L.L.C.
1.93M
2.32%
+69.77K
+3.76%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
Invesco NASDAQ Future Gen 200 ETF
0.48%
Inspire Small/Mid Cap ESG ETF
0.18%
iShares Micro-Cap ETF
0.05%
Federated Hermes MDT Small Cap Core ETF
0.05%
Fidelity Enhanced Small Cap ETF
0.03%
Invesco Nasdaq Biotechnology ETF
0.02%
iShares Biotechnology ETF
0.02%
ProShares Ultra Nasdaq Biotechnology
0.02%
iShares Russell 2000 ETF
0.01%
ProShares Hedge Replication ETF
0.01%
查看更多
Invesco NASDAQ Future Gen 200 ETF
佔比0.48%
Inspire Small/Mid Cap ESG ETF
佔比0.18%
iShares Micro-Cap ETF
佔比0.05%
Federated Hermes MDT Small Cap Core ETF
佔比0.05%
Fidelity Enhanced Small Cap ETF
佔比0.03%
Invesco Nasdaq Biotechnology ETF
佔比0.02%
iShares Biotechnology ETF
佔比0.02%
ProShares Ultra Nasdaq Biotechnology
佔比0.02%
iShares Russell 2000 ETF
佔比0.01%
ProShares Hedge Replication ETF
佔比0.01%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
